The effect of ketanserin on healing of fresh surgical wounds

Summary This study was designed to investigate the effect of topical ketanserin, a selective S2‐serotonin antagonist, on wound healing and contraction in surgical wounds allowed to heal by second intention. Thirty‐five patients applied placebo or 2% ketanserin gel, double‐blind, to head and neck wounds resulting from skin tumour excision, and allowed to heal by second intention. Healing rate was assessed from the change in the square root of wound area, and in 11 patients wound contraction was assessed by the change in the area delineated by wound margin tattoo marks. There were no significant differences in any of the measurements made between the ketanserin‐ and placebo gel‐treated patients. Wound healing was significantly faster in large wounds. Wound contraction was greatest in the early stages of healing, and accounted for 53% of healing.

[1]  N J Levell,et al.  The use of a digitizer to measure area in dermatology. , 1993, Physiological measurement.

[2]  P. G. Lang,et al.  Daily observations during healing of a full-thickness human surgical wound by second intention. , 1991, The Journal of dermatologic surgery and oncology.

[3]  J. Symoens,et al.  Ketanserin in the Treatment of Peripheral Vascular Disease or Hypertension in Patients with Diabetes Mellitus: A Review , 1991, Journal of cardiovascular pharmacology.

[4]  H. Janssen,et al.  Ketanserin promotes wound healing: clinical and preclinical results. , 1991, Progress in clinical and biological research.

[5]  J. Apelqvist,et al.  Ketanserin in the treatment of diabetic foot ulcer with severe peripheral vascular disease. , 1990, International angiology : a journal of the International Union of Angiology.

[6]  S Senn,et al.  Analysis of serial measurements in medical research. , 1990, BMJ.

[7]  J. Symoens,et al.  Ketanserin: A novel cardiovascular drug , 1986 .

[8]  P. Lewi,et al.  Use of topical ketanserin in the treatment of skin ulcers: a double-blind study. , 1989, Journal of the American Academy of Dermatology.

[9]  C. Bunker,et al.  Chronic leg ulceration with livedoid vasculitis, and response to oral ketanserin , 1989, The British journal of dermatology.

[10]  P. Roelens.  Double-blind placebo-controlled study with topical 2% ketanserin ointment in the treatment of venous ulcers. , 1989, Dermatologica.

[11]  J. S. Comaish,et al.  Excision of skin tumours without wound closure , 1986, The British journal of dermatology.

[12]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[13]  N. Cox,et al.  Points: Computer controlled repeat prescribing , 1984, British medical journal.

[14]  E. Seem,et al.  Treatment of Raynaud's phenomenon with ketanserin in patients with connective tissue disorders. , 1984, British medical journal.

[15]  J. Zitelli.  Wound healing by secondary intention. A cosmetic appraisal. , 1983, Journal of the American Academy of Dermatology.

[16]  J. Symoens,et al.  ACUTE BLOOD-PRESSURE-LOWERING EFFECT OF KETANSERIN , 1981, The Lancet.

[17]  K. Bland.  Chemosurgery: Microscopically Controlled Surgery for Skin Cancer , 1980 .

[18]  Danopoulos Ed,et al.  Letter: Urea treatment of skin malignancies. , 1974 .

[19]  N. Hugo.  WOUND HEALING, SECONDARY INTENTION , 1974 .

[20]  R. Catty.  Healing and contraction of experimental full‐thickness wounds in the human , 1965, The British journal of surgery.

[21]  A. Beckett,et al.  AKUFO AND IBARAPA. , 1965, Lancet.

[22]  J. Joseph,et al.  The contribution of migratory epithelium and the relation of wound enlargement to healing. , 1961, Journal of anatomy.